Skip to content

Jeffrey A Meckler, Director at Travere Therapeutics, sold TVTX on Sep 10, 2026

Data as of Oct 16

▼ SELL$111K1,700 shares at $65.39Jeffrey A Meckler DirectorTVTX Travere Therapeutics, Inc.
Watch TVTX
Traded
Sep 10, 2026
Disclosed
Sep 11, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Jeffrey A Meckler, Director at Travere Therapeutics, sold TVTX on Sep 10, 2026TRADEDDISCLOSED
TVTXSimilar stocks (XLV — its sector index fund), rebased to TVTX's price on the disclosure day
TVTX since disclosure
−25.0%
after the sale
Similar stocks (XLV) since disclosure
+6.9%
XLV — its sector index fund

Change in closing price from Sep 11, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLJeffrey A Meckler DirectorTVTX Travere Therapeutics, Inc.$79.4Kdisclosed Sep 11 · filed 1 day after the trade
  2. ▼ SELLJeffrey A Meckler DirectorTVTX Travere Therapeutics, Inc.$944Kdisclosed Sep 11 · filed 1 day after the trade
  3. ▼ SELLJeffrey A Meckler DirectorTVTX Travere Therapeutics, Inc.$211Kdisclosed Sep 11 · filed 1 day after the trade

See every trade on TVTX →